Global Long-Acting Injectables Market Size, Status and Forecast 2020-2026

    • ID: AR2947299
    • 30 July, 2020
    • Other
    • Region: Global
    • 93 Pages
    • QYResearch

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Long-Acting Injectables Revenue
    • 1.4 Market by Type
      • 1.4.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Small and Middle Sized Molecule
      • 1.4.3 Large Sized Molecule
    • 1.5 Market by Application
      • 1.5.1 Global Long-Acting Injectables Market Share by Application: 2020 VS 2026
      • 1.5.2 Schizophrenia
      • 1.5.3 Other Psychotic Disorders
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Global Long-Acting Injectables Market Perspective (2015-2026)
    • 2.2 Global Long-Acting Injectables Growth Trends by Regions
      • 2.2.1 Long-Acting Injectables Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Long-Acting Injectables Historic Market Share by Regions (2015-2020)
      • 2.2.3 Long-Acting Injectables Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Long-Acting Injectables Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Long-Acting Injectables Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Long-Acting Injectables Players by Market Size
      • 3.1.1 Global Top Long-Acting Injectables Players by Revenue (2015-2020)
      • 3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Long-Acting Injectables Market Concentration Ratio
      • 3.2.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2019
    • 3.3 Long-Acting Injectables Key Players Head office and Area Served
    • 3.4 Key Players Long-Acting Injectables Product Solution and Service
    • 3.5 Date of Enter into Long-Acting Injectables Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global Long-Acting Injectables Historic Market Size by Type (2015-2020)
    • 4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2021-2026)

    5 Market Size by Application (2015-2026)

    • 5.1 Global Long-Acting Injectables Market Size by Application (2015-2020)
    • 5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Long-Acting Injectables Market Size (2015-2020)
    • 6.2 Long-Acting Injectables Key Players in North America (2019-2020)
    • 6.3 North America Long-Acting Injectables Market Size by Type (2015-2020)
    • 6.4 North America Long-Acting Injectables Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Long-Acting Injectables Market Size (2015-2020)
    • 7.2 Long-Acting Injectables Key Players in Europe (2019-2020)
    • 7.3 Europe Long-Acting Injectables Market Size by Type (2015-2020)
    • 7.4 Europe Long-Acting Injectables Market Size by Application (2015-2020)

    8 China

    • 8.1 China Long-Acting Injectables Market Size (2015-2020)
    • 8.2 Long-Acting Injectables Key Players in China (2019-2020)
    • 8.3 China Long-Acting Injectables Market Size by Type (2015-2020)
    • 8.4 China Long-Acting Injectables Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Long-Acting Injectables Market Size (2015-2020)
    • 9.2 Long-Acting Injectables Key Players in Japan (2019-2020)
    • 9.3 Japan Long-Acting Injectables Market Size by Type (2015-2020)
    • 9.4 Japan Long-Acting Injectables Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Long-Acting Injectables Market Size (2015-2020)
    • 10.2 Long-Acting Injectables Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Long-Acting Injectables Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Long-Acting Injectables Market Size by Application (2015-2020)

    11 India

    • 11.1 India Long-Acting Injectables Market Size (2015-2020)
    • 11.2 Long-Acting Injectables Key Players in India (2019-2020)
    • 11.3 India Long-Acting Injectables Market Size by Type (2015-2020)
    • 11.4 India Long-Acting Injectables Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Long-Acting Injectables Market Size (2015-2020)
    • 12.2 Long-Acting Injectables Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Long-Acting Injectables Market Size by Type (2015-2020)
    • 12.4 Central & South America Long-Acting Injectables Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Eli Lilly
      • 13.1.1 Eli Lilly Company Details
      • 13.1.2 Eli Lilly Business Overview
      • 13.1.3 Eli Lilly Long-Acting Injectables Introduction
      • 13.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2015-2020))
      • 13.1.5 Eli Lilly Recent Development
    • 13.2 Pfizer
      • 13.2.1 Pfizer Company Details
      • 13.2.2 Pfizer Business Overview
      • 13.2.3 Pfizer Long-Acting Injectables Introduction
      • 13.2.4 Pfizer Revenue in Long-Acting Injectables Business (2015-2020)
      • 13.2.5 Pfizer Recent Development
    • 13.3 GlaxoSmithKline
      • 13.3.1 GlaxoSmithKline Company Details
      • 13.3.2 GlaxoSmithKline Business Overview
      • 13.3.3 GlaxoSmithKline Long-Acting Injectables Introduction
      • 13.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2015-2020)
      • 13.3.5 GlaxoSmithKline Recent Development
    • 13.4 Johnson & Johnson
      • 13.4.1 Johnson & Johnson Company Details
      • 13.4.2 Johnson & Johnson Business Overview
      • 13.4.3 Johnson & Johnson Long-Acting Injectables Introduction
      • 13.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2015-2020)
      • 13.4.5 Johnson & Johnson Recent Development
    • 13.5 Lupin Limited
      • 13.5.1 Lupin Limited Company Details
      • 13.5.2 Lupin Limited Business Overview
      • 13.5.3 Lupin Limited Long-Acting Injectables Introduction
      • 13.5.4 Lupin Limited Revenue in Long-Acting Injectables Business (2015-2020)
      • 13.5.5 Lupin Limited Recent Development
    • 13.6 Zogenix
      • 13.6.1 Zogenix Company Details
      • 13.6.2 Zogenix Business Overview
      • 13.6.3 Zogenix Long-Acting Injectables Introduction
      • 13.6.4 Zogenix Revenue in Long-Acting Injectables Business (2015-2020)
      • 13.6.5 Zogenix Recent Development
    • 13.7 DURECT
      • 13.7.1 DURECT Company Details
      • 13.7.2 DURECT Business Overview
      • 13.7.3 DURECT Long-Acting Injectables Introduction
      • 13.7.4 DURECT Revenue in Long-Acting Injectables Business (2015-2020)
      • 13.7.5 DURECT Recent Development
    • 13.8 Medincel
      • 13.8.1 Medincel Company Details
      • 13.8.2 Medincel Business Overview
      • 13.8.3 Medincel Long-Acting Injectables Introduction
      • 13.8.4 Medincel Revenue in Long-Acting Injectables Business (2015-2020)
      • 13.8.5 Medincel Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      Long-Acting Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Long-Acting Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      The key players covered in this study
      Eli Lilly
      Pfizer
      GlaxoSmithKline
      Johnson & Johnson
      Lupin Limited
      Zogenix
      DURECT
      Medincel

      Market segment by Type, the product can be split into
      Small and Middle Sized Molecule
      Large Sized Molecule
      Market segment by Application, split into
      Schizophrenia
      Other Psychotic Disorders

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America



      Summary:
      Long-Acting Injectables Market Research Report is about Long-Acting Injectables Industry study. Get complete Long-Acting Injectables market research report published after Market Study, Industrial Analysis with Trends & Statistics. Long-Acting Injectables Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED